Stammdaten
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Unternehmen & Branche
| Name | BIOMERICA INC |
|---|---|
| Ticker | BMRA |
| CIK | 0000073290 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 2835 · In Vitro & In Vivo Diagnostic Substances |
Wertpapier & Kennzahlen
| CUSIP | 09061H307 |
|---|---|
| ISIN | US09061H3075 |
| Typ | Common Stock |
| Marktkapitalisierung | 6,8 Mio. USD |
| Beta | 0,20 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-02-28 | 10-Q | 987,000 | -1,312,000 | -0.44 | 4,878,000 | 3,317,000 |
| 2025-11-30 | 10-Q | 1,210,000 | -1,320,000 | -0.45 | 6,034,000 | 4,435,000 |
| 2025-08-31 | 10-Q | 1,380,000 | 2,000 | 0.00 | 6,854,000 | 5,155,000 |
| 2025-05-31 | 10-K | 5,311,000 | -4,973,000 | -2.16 | 5,945,000 | 4,105,000 |
| 2025-02-28 | 10-Q | 1,119,000 | -1,163,000 | -0.48 | 7,376,000 | 5,534,000 |
| 2024-11-30 | 10-Q | 1,636,000 | -950,000 | -0.06 | 7,274,000 | 5,114,000 |
| 2024-08-31 | 10-Q | 1,807,000 | -1,316,000 | -0.63 | 7,870,000 | 5,346,000 |
| 2024-05-31 | 10-K | 5,415,000 | -5,978,000 | -2.84 | 9,254,000 | 6,591,000 |
| 2024-02-29 | 10-Q | 1,017,000 | -1,918,000 | -0.11 | 10,342,000 | 7,808,000 |
| 2023-11-30 | 10-Q | 1,567,000 | -1,507,000 | -0.09 | 11,831,000 | 9,383,000 |
| 2023-08-31 | 10-Q | 1,713,000 | -1,132,000 | -0.07 | 13,219,000 | 10,768,000 |
| 2023-05-31 | 10-K | 5,339,000 | -7,140,000 | -0.50 | 14,454,000 | 11,724,000 |
| 2023-02-28 | 10-Q | 1,111,000 | -1,650,000 | -0.12 | 8,210,168 | 5,988,000 |
| 2022-11-30 | 10-Q | 1,482,000 | -1,626,000 | -0.12 | 9,907,547 | 7,244,000 |
| 2022-08-31 | 10-Q | 1,637,000 | -2,072,000 | -0.16 | 11,050,074 | 8,322,000 |
| 2022-05-31 | 10-K | 18,871,000 | -4,531,000 | -0.36 | 11,374,000 | 8,325,000 |
| 2022-02-28 | 10-Q | 7,660,501 | -104,168 | -0.01 | 17,560,333 | 9,757,802 |
| 2021-11-30 | 10-Q | 4,646,900 | -1,125,274 | -0.09 | 14,809,120 | 8,901,427 |
| 2021-08-31 | 10-Q | 1,261,787 | -1,542,581 | -0.12 | 11,516,047 | 8,803,056 |
| 2021-05-31 | 10-K | 7,199,027 | -7,446,254 | -0.62 | 11,818,813 | 9,228,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 21,127 | 0 | 21,127 | 53,240 | Neu | +100,0% | |
| BlackRock, Inc. | 18,636 | 0 | 18,636 | 46,963 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 18,627 | 0 | 18,627 | 46,949 | Neu | +100,0% | |
| DRW Securities, LLC | 16,925 | 0 | 16,925 | 42,651 | Neu | +100,0% | |
| UBS Group AG | 5,812 | 0 | 5,812 | 14,646 | Neu | +100,0% | |
| CITIGROUP INC | 2,433 | 0 | 2,433 | 6,131 | Neu | +100,0% | |
| HOLLENCREST CAPITAL MANAGEMENT | 1,450 | 0 | 1,450 | 3,654 | Neu | +100,0% | |
| CIBC Private Wealth Group LLC | 662 | 0 | 662 | 1,668 | Neu | +100,0% | |
| HARBOUR INVESTMENTS, INC. | 125 | 0 | 125 | 315 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 49 | 0 | 49 | 124 | Neu | +100,0% | |
| SBI Securities Co., Ltd. | 2 | 0 | 2 | 5 | Neu | +100,0% | |
| DANSKE BANK A/S | 1 | 0 | 1 | 3 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| VANGUARD GROUP INC | 21,127 | 53,240 | 24.61 |
| BlackRock, Inc. | 18,636 | 46,963 | 21.71 |
| GEODE CAPITAL MANAGEMENT, LLC | 18,627 | 46,949 | 21.70 |
| DRW Securities, LLC | 16,925 | 42,651 | 19.71 |
| UBS Group AG | 5,812 | 14,646 | 6.77 |
| CITIGROUP INC | 2,433 | 6,131 | 2.83 |
| HOLLENCREST CAPITAL MANAGEMENT | 1,450 | 3,654 | 1.69 |
| CIBC Private Wealth Group LLC | 662 | 1,668 | 0.77 |
| HARBOUR INVESTMENTS, INC. | 125 | 315 | 0.15 |
| BANK OF AMERICA CORP /DE/ | 49 | 124 | 0.06 |
| SBI Securities Co., Ltd. | 2 | 5 | 0.00 |
| DANSKE BANK A/S | 1 | 3 | 0.00 |